Raymond Dingledine

30.2k total citations · 7 hit papers
234 papers, 24.1k citations indexed

About

Raymond Dingledine is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Raymond Dingledine has authored 234 papers receiving a total of 24.1k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Cellular and Molecular Neuroscience, 128 papers in Molecular Biology and 36 papers in Psychiatry and Mental health. Recurrent topics in Raymond Dingledine's work include Neuroscience and Neuropharmacology Research (151 papers), Receptor Mechanisms and Signaling (41 papers) and Ion channel regulation and function (40 papers). Raymond Dingledine is often cited by papers focused on Neuroscience and Neuropharmacology Research (151 papers), Receptor Mechanisms and Signaling (41 papers) and Ion channel regulation and function (40 papers). Raymond Dingledine collaborates with scholars based in United States, United Kingdom and Norway. Raymond Dingledine's co-authors include Stephen F. Traynelis, Karin Borges, Derek Bowie, John Kelly, Chris J. McBain, Scott J. Myers, Jianxiong Jiang, Hongjie Yuan, Lonnie P. Wollmuth and Kasper B. Hansen and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Raymond Dingledine

232 papers receiving 23.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutamate Receptor Ion Channels: Structure, Regulation, and Function

2010 2.7k citations Scott J. Myers, Raymond Dingledine et al. profile →
The Glutamate Receptor Ion Channels

1999 1.8k citations Raymond Dingledine, Karin Borges et al. profile →
The glutamate receptor ion channels.

1999 1.4k citations Raymond Dingledine, Karin Borges et al. profile →
Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes

1988 1.1k citations Raymond Dingledine et al. profile →
Opiates and endogenous opioid peptides

1977 986 citations Raymond Dingledine et al. profile →
Identification of a Site in Glutamate Receptor Subunits That Controls Calcium Permeability

1991 604 citations Richard I. Hume, Raymond Dingledine et al. profile →
The role of inflammation in epileptogenesis

2012 387 citations Annamaria Vezzani, Alon Friedman et al. Neuropharmacology profile →

Peers

Countries citing papers authored by Raymond Dingledine

Since Specialization

Citations

This map shows the geographic impact of Raymond Dingledine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Dingledine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Dingledine more than expected).

Fields of papers citing papers by Raymond Dingledine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Dingledine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Dingledine. The network helps show where Raymond Dingledine may publish in the future.

Co-authorship network of co-authors of Raymond Dingledine

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Dingledine. A scholar is included among the top collaborators of Raymond Dingledine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Dingledine. Raymond Dingledine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disease modification upon 2 weeks of tofacitinib treatment in a mouse model of chronic epilepsy 2025 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Barry Schoenike, Claudia Espinosa‐García, Felipe Paredes, Nicholas H. Varvel, Raymond Dingledine, Jamie Maguire, Avtar Roopra	1
2	Preclinical development of an EP2 antagonist for post-seizure cognitive deficits 2022 ·Neuropharmacology ·Nicholas H. Varvel, (unknown), Claudia Espinosa‐García, Steven K. Duddy, Ronald B. Franklin, Avijit Banik, (unknown), (unknown), (unknown), Tage Honoré, Thota Ganesh, Raymond Dingledine	9
3	A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy 2019 ·PLoS ONE ·(unknown), Barry Schoenike, (unknown), Heidi L. Grabenstatter, (unknown), (unknown), Margaret Johnson, (unknown), Rama Maganti, Raymond Dingledine, Avtar Roopra	14
4	Neuroinflammatory targets and treatments for epilepsy validated in experimental models 2017 ·Epilepsia ·Eleonora Aronica, Sebastian Bauer, Yuri Bozzi, Matteo Caleo, Raymond Dingledine, Jan A. Gorter, David C. Henshall, Daniela Kaufer, Sookyong Koh, Wolfgang Löscher, Jean‐Pierre Louboutin, Michele Mishto, Braxton A. Norwood, Eleonora Palma, Michael O. Poulter, Gaetano Terrone, Annamaria Vezzani, Rafał M. Kamiński	151
5	The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus 2014 ·Neurobiology of Disease ·Asheebo Rojas, (unknown), Nadia Lelutiu, Yi Quan, Reneé Shaw, Raymond Dingledine	32
6	Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection 2013 ·Trends in Pharmacological Sciences ·Jianxiong Jiang, Raymond Dingledine	131
7	Activation of Group I Metabotropic Glutamate Receptors Potentiates Heteromeric Kainate Receptors 2012 ·Molecular Pharmacology ·Asheebo Rojas, (unknown), Reneé Shaw, Geidy E. Serrano, Sharon A. Swanger, Raymond Dingledine	9
8	A Dual-Readout F ² Assay That Combines Fluorescence Resonance Energy Transfer and Fluorescence Polarization for Monitoring Bimolecular Interactions 2011 ·Assay and Drug Development Technologies ·Yuhong Du, Zaneta Nikolovska‐Coleska, Min Qui, Lian Li, Iestyn Lewis, Raymond Dingledine, Jeanne A. Stuckey, Krzysztof Krajewski, Peter P. Roller, Shaomeng Wang, Haian Fu	16
9	Molecular cascades that mediate the influence of inflammation on epilepsy 2011 ·Epilepsia ·Alon Friedman, Raymond Dingledine	114
10	Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors 2010 ·Brain Research ·Morris Benveniste, Jennifer C. Wilhelm, Raymond Dingledine, David D. Mott	11
11	Region‐specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin 2010 ·Epilepsia ·Bjørnar Hassel, Erik Taubøll, Reneé Shaw, Leif Gjerstad, Raymond Dingledine	12
12	pH-Dependent Inhibition of Kainate Receptors by Zinc 2008 ·Journal of Neuroscience ·David D. Mott, Morris Benveniste, Raymond Dingledine	59
13	Astrocytes in the Epileptic Brain 2008 ·Neuron ·(unknown), Geidy E. Serrano, Raymond Dingledine	304
14	Automated, Quantitative Screening Assay for Antiangiogenic Compounds Using Transgenic Zebrafish 2007 ·Cancer Research ·(unknown), Blossom Sneed, Jamil Haider, Delali Blavo, Audrey White, (unknown), Timothy C. Baranowski, Amy L. Rubinstein, Thanh N. Doan, Raymond Dingledine, Eric M. Sandberg	183
15	Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice 2004 ·Experimental Neurology ·Karin Borges, (unknown), Raymond Dingledine	37
16	Transcriptional regulation of the GluR2 gene: Neural-specific expression, multiple promoters, and regulatory elements 1998 ·Journal of Neuroscience Nursing ·Scott J. Myers, J Peters, Yunfei Huang, Mary B. Comer, F. Barthel, Raymond Dingledine	86
17	Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Mark Washburn, Raymond Dingledine	149
18	MOLECULAR BIOLOGY OF THE GLUTAMATE RECEPTORS 1992 ·Clinical Neuropharmacology ·Jim Boulter, Bernhard Bettler, Raymond Dingledine, (unknown), Melissa Hartley, Irm Hermans‐Borgmeyer, Michael Hollmann, Richard I. Hume, (unknown), Steve Heinemann	11
19	Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes. 1990 ·Molecular Pharmacology ·Thomas L. Dawson, Robert A. Nicholas, Raymond Dingledine	24
20	Midbrain reticular evoked inhibition of thalamic neurones [proceedings]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Raymond Dingledine, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact